Myo-Inositol Plus
Natural health product licensed in Canada
- Licence holder
- Bioclinic Naturals Inc.
- NPN or DIN-HM
- 80087737
- Status
- Active licence
- Licence date
- 10 August 2018
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Myo-inositol Source : Inositol | 2 Grammes | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 1.5 microgrammes | Not calculated |
| D-Chiro-inositol Source : D-Chiro-inositol | 50 milligramme | Not calculated |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 200 microgrammes | Not calculated |
Non-medicinal ingredients
Poudre d'enveloppes d'Oryza sativa (Riz)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Portion(s) | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamins, factors in the maintenance of good health. Source of vitamins, factors in normal growth and development. Source of vitamins to support biological functions which play a key role in the maintenance of good health. Multi-vitamin supplement. Vitamin supplement. May help to support in vitro fertilization outcomes in women with polycystic ovarian disease. May support oocyte (egg) quality in women with polycystic ovarian disease. Aids in the management of PCOS's hormonal and metabolic conditions by promoting healthy glucose metabolism and reducing insulin resistance. Helps to reduce serum testosterone in women with PCOS. May help to support normal menstrual cycle in women with polycystic ovarian disease. Helps to form red blood cells. Helps to support normal early fetal development. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps to maintain the body's ability to metabolize nutrients. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps in the normal function of the immune system. Helps in energy metabolism in the body. Helps prevent vitamin B12 deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087737
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.